Jun 12, 2019 / 03:00PM GMT
Maryana Ilya Breitman - Goldman Sachs Group Inc., Research Division - Research Analyst
Good morning. My name is Maryana Breitman. I am a biotech analyst at Goldman Sachs. And firstly, I will read the disclaimer. We're required to make certain disclosures in public appearances about Goldman Sachs' relationships with companies that we discuss. The disclosures relate to [national] banking relationships, compensation received of 1% or more ownership. We're prepared to read out our disclosures for any issue or upon request. However, these disclosures are available in our most recent reports available to you as required on our firm's portal. Disclosures and updates to those disclosures are also available by ticker on the firm's public website. Also the news stated by non-Goldman Sachs personnel do not necessarily reflect those of Goldman Sachs.
It is my pleasure to welcome John Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics. Thanks, John.
John F. Crowley - Amicus Therapeutics, Inc. - Chairman & CEO
Maryana, good morning.
Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 12, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers